Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.606810
Title: Tumour-mediated immunosuppression of antigen presenting cells: a potential target for cancer immunotherapy
Author: El Refaee, Mohamed
Awarding Body: University of Nottingham
Current Institution: University of Nottingham
Date of Award: 2013
Availability of Full Text:
Full text unavailable from EThOS. Restricted access.
Please contact the current institution’s library for further details.
Abstract:
Tumour escapes from immunosurvillence though tumour-mediated suppression. Tumour disrupts dendritic cells (DC) and macrophage functions and interferes with developing anti-tumour microenvironment. Indeed, DC dysfunction in cancer is a limiting factor in cancer immunotherapy. The hypothesis that alternation of DC MAPK pathway is a strategy by which tumours evade immunosurvillence was tested. Our results revealed that, tumours exploit DC through manipulation of ERK signalling pathway which resulting in inhibition of IL-12 production. In addition, tumours suppress the fibroblasts induced IL-23 production by DC. Through Interfering with IL- 12 and IL-23 production, tumours down regulate immediate inflammatory response responsible for defending against the newly developed malignancy. Similarly, our results on monocyte/ macrophage lineage showed that tumour alternate their function away from pro-inflammatory activity and closer to the regulatory profile.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.606810  DOI: Not available
Share: